WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Up 0.9% – Here’s What Happened
by Scott Moore · The Cerbat GemWuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) traded up 0.9% during trading on Monday . The stock traded as high as $9.12 and last traded at $8.76. 25,876 shares were traded during mid-day trading, a decline of 41% from the average session volume of 43,666 shares. The stock had previously closed at $8.68.
Analyst Ratings Changes
Separately, UBS Group upgraded shares of WuXi Biologics (Cayman) to a “buy” rating in a report on Thursday, August 7th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Buy”.
Read Our Latest Report on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Stock Up 0.9%
The business has a 50 day moving average of $9.68 and a 200 day moving average of $7.85.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc, an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC.
Featured Articles
- Five stocks we like better than WuXi Biologics (Cayman)
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Insiders Sold Big at These 3 Stocks—Should You Worry?
- What Are Dividend Champions? How to Invest in the Champions
- Shares Down, Price Targets Up: 3 Stocks Upgraded After +10% Drops
- NYSE Stocks Give Investors a Variety of Quality Options
- Nuclear Stocks Are Melting Down—Should Investors Panic?